{
    "organizations": [],
    "uuid": "a7c21d1e01b95289a2aff0edeedadf85d752a13e",
    "author": "Preetika Rana",
    "url": "https://www.wsj.com/articles/takeda-nears-shire-deal-as-japan-inc-chases-growth-overseas-1524659165",
    "ord_in_thread": 0,
    "title": "Takeda Nears Shire Deal as Japanese Companies Chase Growth Overseas",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Takeda Pharmaceutical Co. is near a deal worth more than $60 billion to buy European drugmaker Shire PLC, having raised its bid four times in a sign of how ardently Japan’s legacy companies are chasing growth abroad as sales at home slow.\nShire said Wednesday it was willing to recommend that shareholders accept Takeda’s fifth offer—$30.33 in cash and 0.839 Takeda share for each Shire share—culminating a weekslong effort by the Osaka-based company. It has until May 8 to finalize an offer.\n... ",
    "published": "2018-04-25T16:26:00.000+03:00",
    "crawled": "2018-04-25T16:52:56.003+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "takeda",
        "pharmaceutical",
        "near",
        "deal",
        "worth",
        "billion",
        "buy",
        "european",
        "drugmaker",
        "shire",
        "plc",
        "raised",
        "bid",
        "four",
        "time",
        "sign",
        "ardently",
        "japan",
        "legacy",
        "company",
        "chasing",
        "growth",
        "abroad",
        "sale",
        "home",
        "slow",
        "shire",
        "said",
        "wednesday",
        "willing",
        "recommend",
        "shareholder",
        "accept",
        "takeda",
        "fifth",
        "cash",
        "takeda",
        "share",
        "shire",
        "weekslong",
        "effort",
        "company",
        "may",
        "finalize",
        "offer"
    ]
}